Decoy Therapeutics Inc

At Decoy, we are engineering the next generation of peptide conjugate therapies to protect and expand patient lives. Our Platform applies AI/ML for rapid design of therapeutics and uses world-leading fast and scalable manufacturing with our proprietary “single-shot” synthesis technology. Our current focus areas include engineering a new class of broad-acting antivirals, a single drug for multiple pathogens, and GPCR-targeting peptide drug conjugates to treat GI tumors. We believe in developing medicines that are accessible and affordable to everyone, everywhere—empowering communities worldwide to lead healthier lives. Connect with us, and learn more at https://decoytx.com/.